Connect with us

Marijuana Movement

State Legalization and its Adverse Effects on the Medical Marijuana

Published

on

Legalization of Marijuana and its Adverse Effects on the Industry: Recreational vs Medical

Many would think that the legalization of medical cannabis in several states (despite ongoing federal prohibition of cannabis and the substance's classification as a Schedule I substance) would have a positive effect on the overall industry, but early research shows the opposite to be true. In the case of the medical marijuana industry, legalization has cut into its profits significantly in many states. The Associated Press has found that the greater the legalization in a state, the greater the effect on medical marijuana production and profit. In some cases, patients who need it the most are finding it more costly and difficult to access.

The study found that only a few years after legalization in some states, the decline of registered users was more than half. The main reason for this is that many used medical cards to access marijuana legally and not to treat an illness. Once cannabis became legal, they no longer had a use for the cards and got rid of them. For those who do rely on cannabis to treat chronic pain, nausea, or cancer, the change caused shortages and, in some cases, higher prices. Additionally, the recreational industry proved to be more profitable and companies began to focus on higher-margin products such as CBD.

The lack of data, however, proves to be problematic with some states recording more than others. The states that do have ample data, show significant drops in the number of registered patients as well as medical storefronts. Oregon, for example, reported 28,000 patients who had trouble finding affordable products. Marijuana card holders dropped by two thirds in the same state and stores dropped from 400 to only two. Producers are also focusing more on the dry flower market and less on specialized products which many patients still require.

If the goal of legalization is to improve options and increase access, we need to understand how it can affect overall progress. Fortunately, the successes and failures of 11 states can help guide other states who want to follow. The more states that do, will provide further data and greater perception on how to improve the current situation.

All information is for general informational and educational purposes only. Nothing should be interpreted as legal or wellness advice.

Jane is a regular contributor who learned about the great benefits of CBD a few years ago after starting it herself. Impressed by its effects, she's interested in helping others learn about options that can be helpful for them.

Continue Reading

Ultimate CBD Guide


Disclaimer

ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email contact@timesofcbd.com

Copyright © 2020 TimesofCBD.com | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.